John Schroer
Director/Board Member at AZITRA, INC.
Net worth: - $ as of 31/05/2024
Profile
John R.
Schroer is currently serving as an Independent Director at Azitra, Inc. and as the Chief Financial Officer at Alumis, Inc. He previously held positions as the Director of Research at INVESCO Funds Group, Inc., Director & Head-Healthcare at Allianz Global Investors GmbH, Director & Portfolio Manager at Allianz Global Investors U.S.
LLC, Analyst at TCW Asset Management Co. LLC, President at Itros Capital Management LLC, Analyst at HealthCor Management LP, CFO, Treasurer & Principal Accounting Officer at Translate Bio, Inc., President & Chief Investment Officer at Schroer Capital LP, and Chief Financial Officer at Arsenal Biosciences, Inc. Mr. Schroer obtained his undergraduate degree and MBA from the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. -.--% | 01/07/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
John Schroer active positions
| Companies | Position | Start |
|---|---|---|
| AZITRA, INC. | Director/Board Member | - |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | Director of Finance/CFO | 01/05/2022 |
Former positions of John Schroer
| Companies | Position | End |
|---|---|---|
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA. | Director of Finance/CFO | 01/02/2022 |
| TRANSLATE BIO, INC. | Director of Finance/CFO | 27/12/2020 |
Allianz Global Investors U.S. LLC
 Allianz Global Investors U.S. LLC Investment ManagersFinance Allianz Global Investors U.S. LLC (AllianzGI US) is an investment advisory firm headquartered in New York City. The firm was founded in 2001 as Allianz Global Investors Capital LLC. In 2022, Voya Investment Management Co. LLC, which is ultimately owned by Voya Financial, Inc. (NYSE: VOYA), acquired the firm from Allianz SE (ETR: ALV). AllianzGI US provides portfolio management services to a variety of individual and institutional clients as well as certain Wrap Fee Programs. | Head-Equity Investments | 18/05/2018 |
Allianz Global Investors GmbH
 Allianz Global Investors GmbH Investment ManagersFinance Allianz Global Investors GmbH (AGI) is an investment management firm headquartered in Frankfurt, Germany. The was founded in 1956 and is a subsidiary of Allianz Asset Management GmbH, which is owned by Allianz SE (ETR: ALV). AGI manages the group's assets and client-focused equity, fixed-income, and balanced portfolios. They also launch and manage equity and fixed-income mutual funds for individual and institutional clients. | Director/Board Member | 01/04/2018 |
Schroer Capital LP
 Schroer Capital LP Investment ManagersFinance Founded by John Schroer in 2010, Schroer Capital LP is a hedge fund manager located in Greenwood Village, Colorado. The firm provides investment advisory services to the Schroer Capital Partners LP and the Schroer Capital Partners Master Fund LP. | President | 01/12/2013 |
Training of John Schroer
| University of Wisconsin | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AZITRA, INC. | Health Technology |
 | Health Technology |
| Private companies | 9 |
|---|---|
TCW Asset Management Co. LLC
 TCW Asset Management Co. LLC Investment ManagersFinance TCW Asset Management Co. LLC (TCW) is a SEC-registered investment advisor headquartered in Los Angeles, California. The firm was founded in 1992 and is wholly-owned by The TCW Group, Inc. In 2013, TCW management and private investment funds affiliated with The Carlyle Group (NASDAQ: CG) acquired TCW Group from Société Générale. TCW provides investment management and advice for a wide array of investment strategies for institutional and individual investors through investment advisory accounts, private open- and closed-end commingled investment funds and structured investment vehicles such as collateralized debt obligations. | Finance |
INVESCO Funds Group, Inc.
 INVESCO Funds Group, Inc. Investment ManagersFinance Part of Invesco Ltd., INVESCO Funds Group, Inc. is a company based in Denver, CO. | Finance |
Itros Capital Management LLC
 Itros Capital Management LLC Investment ManagersFinance Itros Capital Management LLC is a Denver-based hedge fund firm. | Finance |
HealthCor Management LP
 HealthCor Management LP Investment ManagersFinance HealthCor Management LP (HealthCor) is a holding firm and SEC-registered hedge fund manager headquartered in New York City. The firm was co-founded by Joseph Healey and Arthur Cohen in 2005. HealthCor provides investment management services to several privately offered pooled investment funds and institutional investors through separately managed accounts. | Finance |
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Allianz Global Investors GmbH
Allianz Global Investors GmbH Investment ManagersFinance Allianz Global Investors GmbH (AGI) is an investment management firm headquartered in Frankfurt, Germany. The was founded in 1956 and is a subsidiary of Allianz Asset Management GmbH, which is owned by Allianz SE (ETR: ALV). AGI manages the group's assets and client-focused equity, fixed-income, and balanced portfolios. They also launch and manage equity and fixed-income mutual funds for individual and institutional clients. | Finance |
Allianz Global Investors U.S. LLC
Allianz Global Investors U.S. LLC Investment ManagersFinance Allianz Global Investors U.S. LLC (AllianzGI US) is an investment advisory firm headquartered in New York City. The firm was founded in 2001 as Allianz Global Investors Capital LLC. In 2022, Voya Investment Management Co. LLC, which is ultimately owned by Voya Financial, Inc. (NYSE: VOYA), acquired the firm from Allianz SE (ETR: ALV). AllianzGI US provides portfolio management services to a variety of individual and institutional clients as well as certain Wrap Fee Programs. | Finance |
Schroer Capital LP
Schroer Capital LP Investment ManagersFinance Founded by John Schroer in 2010, Schroer Capital LP is a hedge fund manager located in Greenwood Village, Colorado. The firm provides investment advisory services to the Schroer Capital Partners LP and the Schroer Capital Partners Master Fund LP. | Finance |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA. | Technology Services |
- Stock Market
- Insiders
- John Schroer
